Abstract:The aim of this retrospective study is to describe ocular findings in a large Noonan syndrome cohort and to detect associations between ocular features and genetic mutations that were not found in earlier studies. We collected ophthalmological and genetic data of 105 patients (median age, 12 years; range, 0-60 years) clinically diagnosed as Noonan syndrome. The ocular findings were linked to the genotypes. All patients with Noonan syndrome showed multiple abnormalities in the categories of vision and refraction, external ocular features, ocular alignment and motility, anterior ocular segment, and posterior ocular segment. In total, 50 patients have NS due to a mutation in PTPN11. Permanent visual impairment (bilateral best-corrected visual acuity < 0.3) was found in 7 patients, including patients with a mutation in RAF1, SHOC2, and KRAS. Keratoconus was found in 2 PTPN11 positive patients, and prominent corneal nerves were observed in a patient with a SOS1 mutation. Conclusions: This study shows an overview of ocular abnormalities in Noonan syndrome, including permanent visual impairment caused by binocular optic nerve abnormalities and nystagmus. Delay in ophthalmological diagnosis is still present, also in patients with visual impairment. All Noonan syndrome patients should have a complete ophthalmological examination at the time of diagnosis. What is Known: • Although we discover more pathogenic mutations in patients with Noonan syndrome, Noonan syndrome still is a clinical diagnosis • Ocular features of Noonan syndrome are characterized by developmental anomalies of the eyelids and associated with other ocular abnormalities in childhood (including refractive errors, strabismus and amblyopia). What is New: • There seems to be a delay in the ophthalmological diagnosis and awareness of the broad variety ofophthalmological features including refractive errors and visual impairment in Noonan syndrome is needed. All children should have a full ophthalmological examination at the time of diagnosis. • Permanent visual impairment (best-corrected visual acuity < 0.3) is found in patients with mutations in RAF1, SHOC2, and KRAS and the cause is probably a developmental disorder of the optic nerves.

Molecular And Phenotypic Spectrum Of Noonan Syndrome In Chinese Patients

[Clinical practice guidelines for Noonan syndrome].

Targeted/exome sequencing identified mutations in ten Chinese patients diagnosed with Noonan syndrome and related disorders

A Multicenter Prospective Study of Next-Generation Sequencing-Based Newborn Screening for Monogenic Genetic Diseases in China

New insights on Noonan syndrome's clinical phenotype: a single center retrospective study

Clinical and Genetic Analysis of Noonan Syndrome in 20 Children

Computer-based facial recognition as an assisting diagnostic tool to identify children with Noonan syndrome

Variants of the PTPN11 Gene in Mexican Patients with Noonan Syndrome

Noonan Syndrome: Relation of Genotype to Cardiovascular Phenotype—A Multi-Center Retrospective Study

Mapping the current status and outlook of research on noonan syndrome over the last 26 years: a bibliometric and visual analysis

Case report: A de novo RASopathy-causing SHOC2 variant in a Chinese girl with noonan syndrome-like with loose anagen hair

In-Silico and In-Vitro Analysis of Human SOS1 Protein Causing Noonan Syndrome - A Novel Approach to Explore the Molecular Pathways

Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11

New Insights Into the Spectrum of RASopathies: Clinical and Genetic Data in a Cohort of 121 Spanish Patients

Noonan syndrome caused by mutation of SHOC2 gene: a case report

Microduplication of 3p25.2 Encompassing RAF1 Associated with Congenital Heart Disease Suggestive of Noonan Syndrome

Paternally Inherited Noonan Syndrome Caused by a PTPN11 Variant May Exhibit Mild Symptoms: A Case Report and Literature Review

Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome

Ocular findings in Noonan syndrome: a retrospective cohort study of 105 patients

[New Insight of Craniofacial and Oral Findings of the RASopathies].

Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examined